Predict breast cancer survival model (www.predict.nhs.uk) reaches special landmark...
Professor Gordon Wishart, Check4Cancer’s Chief Medical Officer, is delighted to announce that Check4Cancer and Cigna UK have been shortlisted...
In November 2016, The PREDICT survival model (www.predict.nhs.uk) was one of only two breast cancer prognostic models out of 30 reviewed...
On 17 November 2016, Professor Gordon Wishart gave an invited presentation on “Sentinel node biopsy in early breast cancer” at the XX Russian Oncology Conference in Moscow.
In May 2016, Check4Cancer’s Chief Medical Officer Professor Gordon Wishart launched a nurse-led skin cancer diagnosis service for Cigna-insured patients.
On 4 January 2016, Check4Cancer launched a OneStop diagnostic breast network for Cigna insured clients via its BreastHealth UK brand.
On 8 October 2015 Cigna UK HealthCare Benefits (Cigna) and BreastHealth UK formed an alliance to offer Cigna customers OneStop breast cancer diagnostics from beginning January 2016.
On 27 July 2015, the Nuffield Health opened its brand new state of the art hospital in central Cambridge.
On Monday 6 October 2014, Professor Gordon Wishart, Professor of Cancer Surgery at Anglia Ruskin University & Medical Director of Check4Cancer, was invited to a meeting with the Greek Minister of Health, Mr Mavroudis Voridis in Athens.
Early results from the largest ever randomised trial for lung cancer, using a blood test that detects autoantibody biomarkers, will be released on 7th September at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer.